Publications by authors named "Yusuke Takaki"

Claim this Profile
H
High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia.
Shuki Oya, Hidetoshi Ozawa, Satoshi Morishige, Yoshimi Maehiro, Masahiro Umeda, Yusuke Takaki

Int J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity.
Shuki Oya, Hidetoshi Ozawa, Takayuki Nakamura, Akira Mori, Sorahiko Ochi, Yusuke Takaki

Int J Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful induction therapy for acute myeloid leukemia under management with extracorporeal membrane oxygenation].
Yusuke Takaki, Toshiyuki Yanai, Tatsuhiro Shibata, Takehiro Honma, Maki Otsuka

Rinsho Ketsueki· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies.
Takayuki Nakamura, Shuki Oya, Hidetoshi Ozawa, Yoshimi Maehiro, Seiya Muta, Yusuke Takaki

Int J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful immunosuppressive therapy in female hemophilia A developing inhibitor after perioperative administration of factor VIII products].
Maki Yamaguchi, Yusuke Takaki, Yoshitaka Yamasaki, Shuki Oya, Takayuki Nakamura

Rinsho Ketsueki· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternating venetoclax/azacytidine and FLT3 inhibitor treatment for NPM1- and FLT3-mutated acute myeloid leukemia.
Shuki Oya, Hidetoshi Ozawa, Yoshimi Maehiro, Takayuki Nakamura, Yusuke Takaki

Leuk Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[FLT3-ITD and NPM1 mutation positive acute myeloid leukemia with cuplike blasts mimicking acute promyelocytic leukemia].
Kazutoshi Aoyama, Yoshitaka Yamasaki, Fumihiko Mouri, Yoshimi Maehiro, Yusuke Takaki

Rinsho Ketsueki· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis